Q1 2022 Calliditas Therapeutics AB Earnings Call Transcript
Hello, and welcome to the Calliditas Therapeutics Audiocast with Teleconference Q1 2022. (Operator Instructions) And afterwards, there will be a question-answer session. I will now hand the call over to Renee Aguiar-Lucander, CEO. Please begin your meeting.
()-
Thank you very much, and welcome to this Q1 2022 report from Calliditas Therapeutics. If you turn to Page 2 of the presentation, I would like to draw your attention to the disclaimer page related to forward-looking statements and refer you to the company's reports and other filings, including those which contain risk factor and other relevant sections of our public filings.
On this call today, I am joined by Andrew Udell, President North America; and Fredrik Johansson, Chief Financial Officer.
So if you turn to Page 3. So as you are all aware, it's the last quarter, Calliditas Therapeutics Q4, I would say, achieved a historic milestone in our history. We had our first commercial
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
